AIA Group’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.44M Buy
31,834
+3,721
+13% +$521K 0.06% 169
2025
Q4
$3.45M Sell
28,113
-18,259
-39% -$2.22M 0.05% 186
2025
Q3
$5.15M Buy
46,372
+18,826
+68% +$2.14M 0.09% 140
2025
Q2
$3.05M Buy
27,546
+5,327
+24% +$567K 0.07% 137
2025
Q1
$2.49M Buy
22,219
+7,286
+49% +$752K 0.06% 154
2024
Q4
$1.38M Buy
14,933
+9,664
+183% +$870K 0.03% 183
2024
Q3
$442K Sell
5,269
-18,541
-78% -$1.41M 0.01% 247
2024
Q2
$1.63M Buy
23,810
+814
+4% +$54.3K 0.05% 173
2024
Q1
$1.68M Buy
+22,996
New +$1.77M 0.06% 151
2023
Q4
Sell
-18,206
Closed -$1.36M 279
2023
Q3
$1.36M Sell
18,206
-1,494
-8% -$115K 0.07% 139
2023
Q2
$1.52M Sell
19,700
-505
-2% -$40.3K 0.07% 130
2023
Q1
$1.68M Sell
20,205
-2,971
-13% -$246K 0.09% 97
2022
Q4
$1.99M Buy
23,176
+7,679
+50% +$608K 0.12% 73
2022
Q3
$956K Sell
15,497
-9,550
-38% -$602K 0.06% 128
2022
Q2
$1.55M Buy
25,047
+507
+2% +$31.4K 0.08% 98
2022
Q1
$1.46M Buy
24,540
+18,005
+276% +$1.15M 0.06% 135
2021
Q4
$475K Buy
6,535
+448
+7% +$30.9K 0.02% 184
2021
Q3
$425K Buy
+6,087
New +$428K 0.02% 185
2021
Q2
Sell
-12,596
Closed -$814K 237
2021
Q1
$814K Buy
12,596
+6,978
+124% +$450K 0.12% 91
2020
Q4
$362K Buy
+5,618
New +$339K 0.04% 144

Other funds holding GILD

AIA Group's GILD Position: Q1 2026 in Review

AIA Group increased its Gilead Sciences (GILD) stake by 13% in Q1 2026, buying an estimated $521K and bringing the position to 31,834 shares worth $4.44M. The position accounts for 0.06% of the portfolio, ranked #169.

AIA Group first reported a position in GILD in Q4 2020 and has held it in 20 quarters since. The position peaked at $5.15M in Q3 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • AIA Group held 31,834 shares of Gilead Sciences worth $4.44M as of Q1 2026.
  • AIA Group bought 3,721 Gilead Sciences shares in Q1 2026, an estimated $521K.
  • Gilead Sciences made up 0.06% of AIA Group's portfolio in Q1 2026, its #169 holding.
  • AIA Group first reported a position in Gilead Sciences in Q4 2020 and has held it in 20 quarters since.
  • AIA Group's Gilead Sciences position peaked at $5.15M in Q3 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on AIA Group's 13F filing for Q1 2026, filed 6 May 2026.